Neonatal jaundice
Supplements studied for neonatal jaundice.
Overview
Saccharomyces boulardii (WA 44; low effect size, low evidence, medium trust) has uncertain benefit for neonatal jaundice across two studies. One trial found slightly fewer full-term infants developing jaundice and fewer needing phototherapy; effects in premature or high-risk infants and combined use with light therapy are unclear. Nattokinase (WA 44; low effect size, low evidence, medium trust) has insufficient evidence from one study.
Neither supplement has consistent support for preventing or treating neonatal jaundice. Low ratings reflect the limited and inconclusive trial data available.
See the heatmap and evidence reviews below.
Effect graph
Subscribe to view effect graphs
Interactive visualisations of ranked conditions and clinical benefit with purchase guidance.
Already a subscriber? Sign in
Relevant supplements heatmap
Relevant supplements sorted by DEX Score.
Subscribe to view effect heatmaps
See effect size, evidence strength, and trust at a glance for every condition.
Already a subscriber? Sign in
SupplementDEX Database
2 supplements for rated at least stars. All purchase bands. No minimum star filter.
Subscribe to access the SupplementDEX Database
Read this and 2,600+ other evidence reviews on our practitioner plan.
Already a subscriber? Sign in
Evidence visualised
Subscribe to view condition evidence
Visual summaries of supplement evidence ranked by condition.
Already a subscriber? Sign in